1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6366372A70CB369EB85256EE10053AFBD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-safeguarding-against-counterfeit-products-developing-the-pharmaceutical-brand-security-function?opendocument
18
19opendocument
2034.228.143.13
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services

White Paper: Safeguarding Against Counterfeit Products: Developing the Pharmaceutical Brand Security Function

Whitepaper Image

ID: BEB-08


Pages/Slides: 8


Published: Pre-2013


Delivery Format: PDF


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS

Please click on
"Buy Now" to obtain the free study findings for "Safeguarding Against Counterfeit Products -- Developing the Pharmaceutical Brand Security Function."


If you would like to purchase the full study this summary is based on click here.

Industries Profiled:
Medical Device; Pharmaceutical; Chemical; Biotech; Health Care; Manufacturing


Companies Profiled:
3M Pharmaceuticals; Sanofi-aventis; Solvay America; Procter & Gamble Pharma; Pfizer; Ortho Biotech; Merck Sharp & Dohme (MSD) China; Merck; 3Com; Abbott Laboratories